{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T20:40:16Z","timestamp":1655239216277},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/bmt.2014.295","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T10:36:04Z","timestamp":1423046164000},"page":"161-162","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Can determination of gene polymorphism be of practical value in tailoring the treatment of HSCT patients?"],"prefix":"10.1038","volume":"50","author":[{"given":"A","family":"Lange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Jaskula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,4]]},"reference":[{"key":"BFbmt2014295_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2370.1999.00122.x","volume":"26","author":"V Pravica","year":"1999","unstructured":"Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV . In vitro production of IFN- \u03b3 correlates with CA repeat polymorphism in the human IFN- \u03b3 gene. Eur J Immunogenet 1999; 26: 1\u20133.","journal-title":"Eur J Immunogenet"},{"key":"BFbmt2014295_CR2","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.bbmt.2009.06.008","volume":"15","author":"E Jaskula","year":"2009","unstructured":"Jaskula E, Dlubek D, Duda D, Bogunia-Kubik K, Mlynarczewska A, Lange A . Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transpl 2009; 15: 1296\u20131305.","journal-title":"Biol Blood Marrow Transpl"},{"key":"BFbmt2014295_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bbmt.2013.12.558","volume":"20","author":"E Jaskula","year":"2014","unstructured":"Jaskula E, Lange A, Kyrcz-Krzemien S, Markiewicz M, Dzierzak-Mietla M, Jedrzejczak WW et al. NOD2\/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl 2014; 20: 409\u2013414.","journal-title":"Biol Blood Marrow Transpl"},{"key":"BFbmt2014295_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1042\/BSR20120055","volume":"32","author":"RG Correa","year":"2012","unstructured":"Correa RG, Milutinovic S, Reed JC . Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases. Biosci Rep 2012; 32: 597\u2013608.","journal-title":"Biosci Rep"},{"key":"BFbmt2014295_CR5","doi-asserted-by":"publisher","first-page":"180391","DOI":"10.1155\/2012\/180391","volume":"2012","author":"NP Mayor","year":"2012","unstructured":"Mayor NP, Shaw BE, Madrigal JA, Marsh SGE . NOD2 polymorphisms and their impact on haematopoietic stem cell transplant outcome. Bone Marrow Res 2012; 2012: 180391.","journal-title":"Bone Marrow Res"},{"key":"BFbmt2014295_CR6","doi-asserted-by":"crossref","unstructured":"Shaw BE, Lee F, Krishnamurthy S, Byrne JL, Seedhouse C, Mayor NP et al. Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation. Bone Marrow Transpl 2014, 1\u20137.","DOI":"10.1038\/bmt.2014.238"},{"key":"BFbmt2014295_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/mutage\/ges019","volume":"27","author":"F Zhang","year":"2012","unstructured":"Zhang F, Yang Y, Guo C, Wang Y . CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects. Mutagenesis 2012; 27: 559\u2013566.","journal-title":"Mutagenesis"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2014295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014295","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T20:13:09Z","timestamp":1655237589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2014295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFbmt2014295"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.295","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"4 February 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}